New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Trials supporting FDA approval of breakthrough drugs examined

Trials supporting FDA approval of breakthrough drugs examined

(HealthDay)—Pivotal trials supporting U.S. Food and Drug Administration approvals granted Breakthrough Therapy designation often lack randomization, double-blinding, and control groups, according to a
Oncology April 14,2024
Trials supporting FDA approval of breakthrough drugs examined

Trials supporting FDA approval of breakthrough drugs examined

(HealthDay)—Pivotal trials supporting U.S. Food and Drug Administration approvals granted Breakthrough Therapy designation often lack randomization, double-blinding, and control groups, according to a
Oncology April 14,2024
New international exercise guidelines for cancer survivors

New international exercise guidelines for cancer survivors

by Kerry Blackadar,University of British ColumbiaDr. Kristin Campbell (left), associate professor at UBC's department of physical therapy, with former BC Cancer patient Scenery Slater. Credi
Oncology April 14,2024
New international exercise guidelines for cancer survivors

New international exercise guidelines for cancer survivors

by Kerry Blackadar,University of British ColumbiaDr. Kristin Campbell (left), associate professor at UBC's department of physical therapy, with former BC Cancer patient Scenery Slater. Credi
Oncology April 14,2024
Aromatherapy and reflexology ease side effects for cancer patients

Aromatherapy and reflexology ease side effects for cancer patients

by Amanda Harper,The Ohio State UniversityCredit: CC0 Public DomainA noninvasive approach using aromatherapy and reflexology can dramatically reduce pain and anxiety for women undergoing cervica
Oncology April 14,2024
Aromatherapy and reflexology ease side effects for cancer patients

Aromatherapy and reflexology ease side effects for cancer patients

by Amanda Harper,The Ohio State UniversityCredit: CC0 Public DomainA noninvasive approach using aromatherapy and reflexology can dramatically reduce pain and anxiety for women undergoing cervica
Oncology April 14,2024
Mutation-specific peptide vaccine against midline gliomas used in patients for the first time

Mutation-specific peptide vaccine against midline gliomas used in patients for the first time

by German Cancer Research CenterCredit: Pixabay/CC0 Public DomainTumor vaccines can help the body fight cancer. These vaccines alert the patient's immune system to proteins that are carrying
Oncology April 14,2024
Mutation-specific peptide vaccine against midline gliomas used in patients for the first time

Mutation-specific peptide vaccine against midline gliomas used in patients for the first time

by German Cancer Research CenterCredit: Pixabay/CC0 Public DomainTumor vaccines can help the body fight cancer. These vaccines alert the patient's immune system to proteins that are carrying
Oncology April 14,2024
Metabolic reprogramming of branched-chain amino acid facilitates drug resistance in lung cancer

Metabolic reprogramming of branched-chain amino acid facilitates drug resistance in lung cancer

by Chinese Academy of SciencesCredit: CC0 Public DomainDespite the remarkable success of molecular targeted therapy in recent years, the rapid increase of drug resistance is a major obstacle to e
Oncology April 14,2024
Metabolic reprogramming of branched-chain amino acid facilitates drug resistance in lung cancer

Metabolic reprogramming of branched-chain amino acid facilitates drug resistance in lung cancer

by Chinese Academy of SciencesCredit: CC0 Public DomainDespite the remarkable success of molecular targeted therapy in recent years, the rapid increase of drug resistance is a major obstacle to e
Oncology April 14,2024
Device might detect breast cancer-linked swelling sooner

Device might detect breast cancer-linked swelling sooner

by Maureen Salamon, Healthday Reporter(HealthDay)—Testing for small changes in the flow of lymph fluids after breast cancer surgery can spot the start of a painful swelling known as lymphedema before
Oncology April 14,2024
Device might detect breast cancer-linked swelling sooner

Device might detect breast cancer-linked swelling sooner

by Maureen Salamon, Healthday Reporter(HealthDay)—Testing for small changes in the flow of lymph fluids after breast cancer surgery can spot the start of a painful swelling known as lymphedema before
Oncology April 14,2024
Proving the efficacy of local treatment in liver cancer oligometastases

Proving the efficacy of local treatment in liver cancer oligometastases

by Korea University College of MedicineThe inclusion process. Credit:Cancers(2023). DOI: 10.3390/cancers15133467Professor Chai Hong Rim of the Department of Radiation Oncology, Korea Unive
Oncology April 14,2024
Proving the efficacy of local treatment in liver cancer oligometastases

Proving the efficacy of local treatment in liver cancer oligometastases

by Korea University College of MedicineThe inclusion process. Credit:Cancers(2023). DOI: 10.3390/cancers15133467Professor Chai Hong Rim of the Department of Radiation Oncology, Korea Unive
Oncology April 14,2024
Discovery could improve MDS cancer treatment

Discovery could improve MDS cancer treatment

by Cold Spring Harbor LaboratoryImmature blood cells (stained purple) do not divide into enough functioning red blood cells when defective. Researchers have discovered how to stop the protein sig
Oncology April 14,2024
Discovery could improve MDS cancer treatment

Discovery could improve MDS cancer treatment

by Cold Spring Harbor LaboratoryImmature blood cells (stained purple) do not divide into enough functioning red blood cells when defective. Researchers have discovered how to stop the protein sig
Oncology April 14,2024
New way to target advanced breast cancers

New way to target advanced breast cancers

by Jackson LaboratoryHuman breast cancer tissue stained by immunofluorescence illustrates the interplay between secreted and surface-bound TGFβ (red) expressed by cancer cells (blue), which prime
Oncology April 14,2024
New way to target advanced breast cancers

New way to target advanced breast cancers

by Jackson LaboratoryHuman breast cancer tissue stained by immunofluorescence illustrates the interplay between secreted and surface-bound TGFβ (red) expressed by cancer cells (blue), which prime
Oncology April 14,2024
Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient
Oncology April 14,2024
Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient
Oncology April 14,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com